Therasonic soulève le tour de pré-section

TheraSonic proudly announces a fundraising of 1 million euros to finance the development of its robotic medical device designed to improve drug delivery in the brain through the use of focused ultrasound. This fundraising is led by the European venture studio M2care, created on the initiative of Merieux Developpement, specialized in healthtech. Gustave Roussy Transfert also enters the capital of TheraSonic to enable access to unique clinical expertise.